217 related articles for article (PubMed ID: 23555322)
1. Human papilloma virus infection in head and neck cancer.
Tribius S; Hoffmann M
Dtsch Arztebl Int; 2013 Mar; 110(11):184-90, 190e1. PubMed ID: 23555322
[TBL] [Abstract][Full Text] [Related]
2. [Relevance of HPV infections in head and neck cancers : Highlights of the 2016 ASCO Annual Meeting].
Hoffmann M
HNO; 2016 Oct; 64(10):731-5. PubMed ID: 27601039
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic human papilloma virus vaccination in head and neck: indications and future perspectives.
Wierzbicka M; Berkhof JH; Dikkers FG
Curr Opin Otolaryngol Head Neck Surg; 2019 Apr; 27(2):85-90. PubMed ID: 30694913
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for head and neck cancer of unknown primary including the impact of human papilloma virus infection.
Axelsson L; Nyman J; Haugen-Cange H; Bove M; Johansson L; De Lara S; Kovács A; Hammerlid E
J Otolaryngol Head Neck Surg; 2017 Jun; 46(1):45. PubMed ID: 28601094
[TBL] [Abstract][Full Text] [Related]
5. [Human papilloma virus in head and neck cancer].
Barry B; Ortholan C
Cancer Radiother; 2014 Oct; 18(5-6):430-3. PubMed ID: 25151649
[TBL] [Abstract][Full Text] [Related]
6. Aetiological heterogeneity of head and neck squamous cell carcinomas: the role of human papillomavirus infections, smoking and alcohol.
Farsi NJ; Rousseau MC; Schlecht N; Castonguay G; Allison P; Nguyen-Tan PF; Souliéres D; Coutlée F; Hier M; Madathil S; Franco EL; Nicolau B
Carcinogenesis; 2017 Dec; 38(12):1188-1195. PubMed ID: 29029021
[TBL] [Abstract][Full Text] [Related]
7. [HPV infection in oral, pharyngeal and laryngeal papillomas].
Andratschke M; Hagedorn H; Nerlich AG
HNO; 2015 Nov; 63(11):768-72. PubMed ID: 26507714
[TBL] [Abstract][Full Text] [Related]
8. Could the human papillomavirus vaccination be cost-effective in males for the prevention of oropharyngeal cancer?
Isaranuwatchai W; Graham DM; Siu LL; Hoch JS
Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):763-5. PubMed ID: 25095728
[TBL] [Abstract][Full Text] [Related]
9. HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs?
Takes RP; Wierzbicka M; D'Souza G; Jackowska J; Silver CE; Rodrigo JP; Dikkers FG; Olsen KD; Rinaldo A; Brakenhoff RH; Ferlito A
Oral Oncol; 2015 Dec; 51(12):1057-60. PubMed ID: 26520047
[TBL] [Abstract][Full Text] [Related]
10. [Effect of human papilloma virus infection status on the prognosis of localized stage head and neck squamous cell carcinomas in different ethnic groups of Xinjiang].
Zhang Y; Zhang S; A Er-Zi-Gi TE; Zhao H; Hu Er-Xidan NY; Bao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Dec; 50(12):742-5. PubMed ID: 26887399
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
Berman TA; Schiller JT
Cancer; 2017 Jun; 123(12):2219-2229. PubMed ID: 28346680
[TBL] [Abstract][Full Text] [Related]
12. The changing aetiology of head and neck cancer: the role of human papillomavirus.
Evans M; Powell NG
Clin Oncol (R Coll Radiol); 2010 Sep; 22(7):538-46. PubMed ID: 20584591
[TBL] [Abstract][Full Text] [Related]
13. [Anticipated efficacy of HPV vaccination in prophylaxis against nongenital cancers].
Sehnal B; Vojáčková N; Driák D; Kmoníčková E; Vaňousová D; Maxová K; Neumannová H; Sláma J
Klin Onkol; 2014; 27(4):239-46. PubMed ID: 25115712
[TBL] [Abstract][Full Text] [Related]
14. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
Sano D; Yabuki K; Arai Y; Tanabe T; Chiba Y; Nishimura G; Takahashi H; Yamanaka S; Oridate N
Auris Nasus Larynx; 2018 Jun; 45(3):558-565. PubMed ID: 28760331
[TBL] [Abstract][Full Text] [Related]
15. HPV vaccination in head and neck HPV-related pathologies.
Wierzbicka M; Józefiak A; Jackowska J; Szydłowski J; Goździcka-Józefiak A
Otolaryngol Pol; 2014; 68(4):157-73. PubMed ID: 24981297
[TBL] [Abstract][Full Text] [Related]
16. Impact of the HPV-positivity definition on the prognostic value of HPV status in patients with locally advanced squamous cell carcinoma of the head and neck.
Rades D; Seibold ND; Hoffmann A; Gebhard MP; Noack F; Thorns C; Schild SE
Strahlenther Onkol; 2013 Oct; 189(10):856-60. PubMed ID: 23868550
[TBL] [Abstract][Full Text] [Related]
17. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
[TBL] [Abstract][Full Text] [Related]
19. Human papilloma virus in locally advanced stage III/IV squamous cell cancer of the oropharynx and impact on choice of therapy.
Ihloff AS; Petersen C; Hoffmann M; Knecht R; Tribius S
Oral Oncol; 2010 Oct; 46(10):705-11. PubMed ID: 20843732
[TBL] [Abstract][Full Text] [Related]
20. Risk Groups for Survival in HPV-Positive and HPV-Negative OPSCC.
Rietbergen MM; Brakenhoff RH; René Leemans C
Recent Results Cancer Res; 2017; 206():221-231. PubMed ID: 27699542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]